
LINK . SPRINGER . COM {
}
Title:
Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer | Journal of Experimental & Clinical Cancer Research
Description:
Background Gastric cancer is one of the major causes of cancer-related mortality worldwide. Most of patients presenting with inoperable gastric cancers rely on systemic chemotherapy for prolongation of survival. Doxorubicin (DOX) is one of the important agents against gastric cancer. Acquired DOX-resistance severely impedes the chemotherapeutic effect, invariably leading to poor prognosis. Resveratrol (RES) as a kind of phytoalexin has demonstrated anti-tumor functions in breast cancer and myeloid leukemia, but its function and mechanism are still unknown in gastric cancer treatment. Methods CCK8 assay was used to detect the cytotoxicity of DOX and RES to gastric cancer cells. DOX-resistant subclone cell line (SGC7901/DOX) was derived from SGC7901 cells exposed to stepwise increasing concentrations of DOX treatment. We measured the migratory capabilities of SGC7901/DOX cells by Cell scratch test and Transwell assay. SGC7901/DOX cells were treated with DOX, RES, neither or both. Then we analyzed cell survival by CCK8 assay, colony formation by Colony-forming assay, cell apoptosis by Annexin-V-FITC and PI dual staining assay and cell migration by Cell scratch test and Transwell assay. Western blotting was conducted to detect the protein expressions of PTEN/Akt signaling pathway and EMT-related markers. Immunofluorescence was performed to confirm the EMT-related markers expressions. The xenograft model was used to assess the effect of DOX and RES in vivo. The key molecules associated with proliferation, apoptosis and EMT were evaluated by immunohistochemistry in tumor specimens. Results SGC7901/DOX cells acquired drug resistance and enhancive migratory capability. RES enabled SGC7901/DOX cells to regain DOX sensitivity, mitigated the aggressive biological features, promoted cell apoptosis in vitro and inhibited tumor growth in vivo. Mechanistic studies revealed that SGC7901/DOX cells underwent epithelial-mesenchymal transition (EMT) which was induced by Akt activation, and through activating PTEN, RES inhibited the Akt pathway, and then achieved the reversion of EMT. Conclusion RES serves as a novel solution to reverse the DOX-resistance of gastric cancer via preventing EMT by modulating PTEN/Akt signaling pathway. DOX-RES combined treatment provides a promising future for gastric cancer patients to postpone drug resistance and prolong survival.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We're unsure if the website is profiting.
Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.
Keywords {🔍}
cells, res, dox, cancer, cell, sgcdox, mgl, treatment, gastric, pubmed, article, emt, google, scholar, fig, signaling, assay, vimentin, sgc, cas, resistance, migration, akt, expression, effect, pathway, tumor, survival, apoptosis, pten, treated, combined, caspase, doxorubicin, concentration, βcatenin, data, resveratrol, chemotherapy, drug, group, analysis, ecadherin, image, effects, medium, transition, ptenakt, results, study,
Topics {✒️}
akt/gsk-3beta/beta-catenin signaling akt/gsk-3β/β-catenin pathway doxorubicin-induced epithelial-mesenchymal transition emt-mediated therapeutic resistance 5 μl annexin-v-fitc droplet-based microtumor model trans-membrane sgc7901/dox cells inhibiting epithelial-mesenchymal transition tgf-beta-induced epithelial potent anti-tumor activity pi3k/akt signaling pathway e-cadherin/β-catenin complex article download pdf gas6/axl axis contributes sgc7901/dox cell line cancer-related mortality worldwide pten/akt signaling pathway long-term dox treatment trans-membrane migrating cells annexin-v-fitc β-catenin nuclear tranlocation dox-resistant sgc7901/dox semi-quantitative image analysis emt lineage-tracing system assess cell-ecm interactions illustrates dox-induced emt showed chemo-resistance owing epithelial–mesenchymal transition pten/akt signaling expression demonstrated anti-tumor functions sgc7901/dox cell migration suppress dox-induced emt exhibit chemo-preventive effect prospective clinical trials sgc7901/dox cell survival canonical signaling pathways measeuring emt-related proteins sgc7901/dox cell colonies gold therapy regimen emt-related markers expressions dox-free culture medium multiple drug resistance sgc7901/dox cells reached reverses multidrug-resistance mesenchymal cell markers sgc7901/dox cells enhanced sgc7901/dox cells displayed cell-cell adhesion full size image specific antigen-binding sites
Questions {❓}
- Adenocarcinoma of the stomach: are we making progress?
- Resveratrol supplementation: where are we now and where should we go?
- Targeting the PI3K/Akt signaling pathway in gastric carcinoma: a reality for personalized medicine?
Schema {🗺️}
WebPage:
mainEntity:
headline:Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
description:Gastric cancer is one of the major causes of cancer-related mortality worldwide. Most of patients presenting with inoperable gastric cancers rely on systemic chemotherapy for prolongation of survival. Doxorubicin (DOX) is one of the important agents against gastric cancer. Acquired DOX-resistance severely impedes the chemotherapeutic effect, invariably leading to poor prognosis. Resveratrol (RES) as a kind of phytoalexin has demonstrated anti-tumor functions in breast cancer and myeloid leukemia, but its function and mechanism are still unknown in gastric cancer treatment. CCK8 assay was used to detect the cytotoxicity of DOX and RES to gastric cancer cells. DOX-resistant subclone cell line (SGC7901/DOX) was derived from SGC7901 cells exposed to stepwise increasing concentrations of DOX treatment. We measured the migratory capabilities of SGC7901/DOX cells by Cell scratch test and Transwell assay. SGC7901/DOX cells were treated with DOX, RES, neither or both. Then we analyzed cell survival by CCK8 assay, colony formation by Colony-forming assay, cell apoptosis by Annexin-V-FITC and PI dual staining assay and cell migration by Cell scratch test and Transwell assay. Western blotting was conducted to detect the protein expressions of PTEN/Akt signaling pathway and EMT-related markers. Immunofluorescence was performed to confirm the EMT-related markers expressions. The xenograft model was used to assess the effect of DOX and RES in vivo. The key molecules associated with proliferation, apoptosis and EMT were evaluated by immunohistochemistry in tumor specimens. SGC7901/DOX cells acquired drug resistance and enhancive migratory capability. RES enabled SGC7901/DOX cells to regain DOX sensitivity, mitigated the aggressive biological features, promoted cell apoptosis in vitro and inhibited tumor growth in vivo. Mechanistic studies revealed that SGC7901/DOX cells underwent epithelial-mesenchymal transition (EMT) which was induced by Akt activation, and through activating PTEN, RES inhibited the Akt pathway, and then achieved the reversion of EMT. RES serves as a novel solution to reverse the DOX-resistance of gastric cancer via preventing EMT by modulating PTEN/Akt signaling pathway. DOX-RES combined treatment provides a promising future for gastric cancer patients to postpone drug resistance and prolong survival.
datePublished:2017-01-26T00:00:00Z
dateModified:2023-01-17T00:00:00Z
pageStart:1
pageEnd:14
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13046-016-0487-8
keywords:
Resveratrol
Doxorubicin
Drug resistance
EMT
PTEN/Akt
Cancer Research
Immunology
Apoptosis
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig6_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig7_HTML.gif
isPartOf:
name:Journal of Experimental & Clinical Cancer Research
issn:
1756-9966
volumeNumber:36
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Jiahui Xu
affiliation:
name:Southern Medical University
address:
name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Deying Liu
affiliation:
name:Southern Medical University
address:
name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Huilin Niu
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Guifang Zhu
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yangwei Xu
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Danli Ye
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Jian Li
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Qingling Zhang
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
name:Southern Medical University
address:
name:Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
description:Gastric cancer is one of the major causes of cancer-related mortality worldwide. Most of patients presenting with inoperable gastric cancers rely on systemic chemotherapy for prolongation of survival. Doxorubicin (DOX) is one of the important agents against gastric cancer. Acquired DOX-resistance severely impedes the chemotherapeutic effect, invariably leading to poor prognosis. Resveratrol (RES) as a kind of phytoalexin has demonstrated anti-tumor functions in breast cancer and myeloid leukemia, but its function and mechanism are still unknown in gastric cancer treatment. CCK8 assay was used to detect the cytotoxicity of DOX and RES to gastric cancer cells. DOX-resistant subclone cell line (SGC7901/DOX) was derived from SGC7901 cells exposed to stepwise increasing concentrations of DOX treatment. We measured the migratory capabilities of SGC7901/DOX cells by Cell scratch test and Transwell assay. SGC7901/DOX cells were treated with DOX, RES, neither or both. Then we analyzed cell survival by CCK8 assay, colony formation by Colony-forming assay, cell apoptosis by Annexin-V-FITC and PI dual staining assay and cell migration by Cell scratch test and Transwell assay. Western blotting was conducted to detect the protein expressions of PTEN/Akt signaling pathway and EMT-related markers. Immunofluorescence was performed to confirm the EMT-related markers expressions. The xenograft model was used to assess the effect of DOX and RES in vivo. The key molecules associated with proliferation, apoptosis and EMT were evaluated by immunohistochemistry in tumor specimens. SGC7901/DOX cells acquired drug resistance and enhancive migratory capability. RES enabled SGC7901/DOX cells to regain DOX sensitivity, mitigated the aggressive biological features, promoted cell apoptosis in vitro and inhibited tumor growth in vivo. Mechanistic studies revealed that SGC7901/DOX cells underwent epithelial-mesenchymal transition (EMT) which was induced by Akt activation, and through activating PTEN, RES inhibited the Akt pathway, and then achieved the reversion of EMT. RES serves as a novel solution to reverse the DOX-resistance of gastric cancer via preventing EMT by modulating PTEN/Akt signaling pathway. DOX-RES combined treatment provides a promising future for gastric cancer patients to postpone drug resistance and prolong survival.
datePublished:2017-01-26T00:00:00Z
dateModified:2023-01-17T00:00:00Z
pageStart:1
pageEnd:14
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13046-016-0487-8
keywords:
Resveratrol
Doxorubicin
Drug resistance
EMT
PTEN/Akt
Cancer Research
Immunology
Apoptosis
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig6_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig7_HTML.gif
isPartOf:
name:Journal of Experimental & Clinical Cancer Research
issn:
1756-9966
volumeNumber:36
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Jiahui Xu
affiliation:
name:Southern Medical University
address:
name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Deying Liu
affiliation:
name:Southern Medical University
address:
name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Huilin Niu
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Guifang Zhu
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yangwei Xu
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Danli Ye
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Jian Li
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Qingling Zhang
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
name:Southern Medical University
address:
name:Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Journal of Experimental & Clinical Cancer Research
issn:
1756-9966
volumeNumber:36
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Southern Medical University
address:
name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
type:PostalAddress
name:Southern Medical University
address:
name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
type:PostalAddress
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
name:Southern Medical University
address:
name:Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Jiahui Xu
affiliation:
name:Southern Medical University
address:
name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
name:Deying Liu
affiliation:
name:Southern Medical University
address:
name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
name:Huilin Niu
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
name:Guifang Zhu
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
name:Yangwei Xu
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
name:Danli Ye
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
name:Jian Li
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
name:Qingling Zhang
affiliation:
name:Southern Medical University
address:
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
name:Southern Medical University
address:
name:Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
name:Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China
External Links {🔗}(158)
- How much profit does https://www.springernature.com/gp/authors generate?
- How much money does https://link.springernature.com/home/ generate?
- How much revenue does https://order.springer.com/public/cart produce monthly?
- What's the monthly money flow for https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- How much does https://jeccr.biomedcentral.com/about generate monthly?
- Learn how profitable https://submission.springernature.com/new-submission/13046/3 is on a monthly basis
- How much does https://doi.org/10.1186/s13046-023-02593-5 generate monthly?
- Income figures for https://doi.org/10.3322%2Fcaac.21262
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25651787 generate?
- How much money does http://scholar.google.com/scholar_lookup?&title=Global%20cancer%20statistics%2C%202012&journal=CA%20Cancer%20J%20Clin&doi=10.3322%2Fcaac.21262&volume=65&pages=87-108&publication_year=2015&author=Torre%2CLA&author=Bray%2CF&author=Siegel%2CRL&author=Ferlay%2CJ&author=Lortet-Tieulent%2CJ&author=Jemal%2CA make?
- Discover the revenue of https://doi.org/10.1016%2F0140-6736%2893%2991711-T
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8103825 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Adenocarcinoma%20of%20the%20stomach%3A%20are%20we%20making%20progress%3F&journal=Lancet&doi=10.1016%2F0140-6736%2893%2991711-T&volume=342&pages=713-8&publication_year=1993&author=Thompson%2CGB&author=Heerden%2CJA&author=Sarr%2CMG earn?
- Get to know what's the income of https://doi.org/10.3322%2Fcanjclin.50.1.7
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10735013's gross income?
- How much does http://scholar.google.com/scholar_lookup?&title=Cancer%20statistics%2C%202000&journal=CA%20Cancer%20J%20Clin&doi=10.3322%2Fcanjclin.50.1.7&volume=50&pages=7-33&publication_year=2000&author=Greenlee%2CRT&author=Murray%2CT&author=Bolden%2CS&author=Wingo%2CPA net monthly?
- What is the earnings of https://doi.org/10.1097%2F01.sla.0000143245.28656.15?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15492562 make?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1356486?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Patterns%20of%20initial%20recurrence%20in%20completely%20resected%20gastric%20adenocarcinoma&journal=Ann%20Surg&doi=10.1097%2F01.sla.0000143245.28656.15&volume=240&pages=808-16&publication_year=2004&author=D%E2%80%99Angelica%2CM&author=Gonen%2CM&author=Brennan%2CMF&author=Turnbull%2CAD&author=Bains%2CM&author=Karpeh%2CMS?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8186165 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Initial%20or%20delayed%20chemotherapy%20with%20best%20supportive%20care%20in%20advanced%20gastric%20cancer&journal=Ann%20Oncol&volume=5&pages=189-90&publication_year=1994&author=Glimelius%2CB&author=Hoffman%2CK&author=Haglund%2CU&author=Nyren%2CO&author=Sjoden%2CPO pull in monthly?
- What are the earnings of https://doi.org/10.1038%2Fbjc.1995.114?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7533517 pull in monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033628 produce monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Randomised%20comparison%20of%20fluorouracil%2C%20epidoxorubicin%20and%20methotrexate%20%28FEMTX%29%20plus%20supportive%20care%20with%20supportive%20care%20alone%20in%20patients%20with%20non-resectable%20gastric%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.1995.114&volume=71&pages=587-91&publication_year=1995&author=Pyrhonen%2CS&author=Kuitunen%2CT&author=Nyandoto%2CP&author=Kouri%2CM bring in?
- How much income is https://doi.org/10.7326%2F0003-4819-93-4-533 earning monthly?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7436184?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=5-Fluorouracil%2C%20doxorubicin%2C%20and%20mitomycin%20%28FAM%29%20combination%20chemotherapy%20for%20advanced%20gastric%20cancer&journal=Ann%20Intern%20Med&doi=10.7326%2F0003-4819-93-4-533&volume=93&pages=533-6&publication_year=1980&author=MacDonald%2CJS&author=Schein%2CPS&author=Woolley%2CPV&author=Smythe%2CT&author=Ueno%2CW&author=Hoth%2CD&author=Smith%2CF&author=Boiron%2CM&author=Gisselbrecht%2CC&author=Brunet%2CR&author=Lagarde%2CC
- How profitable is https://doi.org/10.1093%2Fannonc%2Fmdf302?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12419751 makes per month
- How much does http://scholar.google.com/scholar_lookup?&title=A%20phase%20III%20randomized%20trial%20of%205-fluorouracil%2C%20doxorubicin%2C%20and%20mitomycin%20C%20versus%205-fluorouracil%20and%20mitomycin%20C%20versus%205-fluorouracil%20alone%20in%20curatively%20resected%20gastric%20cancer&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdf302&volume=13&pages=1779-85&publication_year=2002&author=Chang%2CHM&author=Jung%2CKH&author=Kim%2CTY&author=Kim%2CWS&author=Yang%2CHK&author=Lee%2CKU&author=Choe%2CKJ&author=Heo%2CDS&author=Bang%2CYJ&author=Kim%2CNK pull in monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8591078 rake in every month?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Adjuvant%20chemotherapy%20with%205-FU%2C%20adriamycin%2C%20and%20mitomycin-C%20%28FAM%29%20versus%20surgery%20alone%20for%20patients%20with%20locally%20advanced%20gastric%20adenocarcinoma%3A%20A%20Southwest%20Oncology%20Group%20study&journal=Ann%20Surg%20Oncol&doi=10.1007%2FBF02307081&volume=2&pages=488-94&publication_year=1995&author=Macdonald%2CJS&author=Fleming%2CTR&author=Peterson%2CRF&author=Berenberg%2CJL&author=McClure%2CS&author=Chapman%2CRA&author=Eyre%2CHJ&author=Solanki%2CD&author=Cruz%2CAB&author=Gagliano%2CR
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7595735
- What's the income of http://scholar.google.com/scholar_lookup?&title=Final%20results%20of%20a%20phase%20III%20clinical%20trial%20of%20adjuvant%20chemotherapy%20with%20the%20modified%20fluorouracil%2C%20doxorubicin%2C%20and%20mitomycin%20regimen%20in%20resectable%20gastric%20cancer&journal=J%20Clin%20Oncol&volume=13&pages=2757-63&publication_year=1995&author=Lise%2CM&author=Nitti%2CD&author=Marchet%2CA&author=Sahmoud%2CT&author=Buyse%2CM&author=Duez%2CN&author=Fiorentino%2CM&author=Santos%2CJG&author=Labianca%2CR&author=Rougier%2CP?
- Revenue of https://doi.org/10.3748%2Fwjg.v20.i2.584
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24574729?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923035 generate?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Chemotherapy%20for%20patients%20with%20gastric%20cancer%20after%20complete%20resection%3A%20a%20network%20meta-analysis&journal=World%20J%20Gastroenterol&doi=10.3748%2Fwjg.v20.i2.584&volume=20&pages=584-92&publication_year=2014&author=Zhang%2CYW&author=Zhang%2CYL&author=Pan%2CH&author=Wei%2CFX&author=Zhang%2CYC&author=Shao%2CY&author=Han%2CW&author=Liu%2CHP&author=Wang%2CZY&author=Yang%2CSH
- Learn about the earnings of https://doi.org/10.1016%2Fj.cbi.2015.02.005
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25686905?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Acquisition%20of%20doxorubicin%20resistance%20facilitates%20migrating%20and%20invasive%20potentials%20of%20gastric%20cancer%20MKN45%20cells%20through%20up-regulating%20aldo-keto%20reductase%201B10&journal=Chem%20Biol%20Interact&doi=10.1016%2Fj.cbi.2015.02.005&volume=230&pages=30-9&publication_year=2015&author=Morikawa%2CY&author=Kezuka%2CC&author=Endo%2CS&author=Ikari%2CA&author=Soda%2CM&author=Yamamura%2CK&author=Toyooka%2CN&author=El-Kabbani%2CO&author=Hara%2CA&author=Matsunaga%2CT bring in?
- Profit of https://doi.org/10.1089%2Fars.2012.4573
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22871022 making per month?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Phytochemicals%20as%20chemosensitizers%3A%20from%20molecular%20mechanism%20to%20clinical%20significance&journal=Antioxid%20Redox%20Signal&doi=10.1089%2Fars.2012.4573&volume=18&pages=1307-48&publication_year=2013&author=Vinod%2CBS&author=Maliekal%2CTT&author=Anto%2CRJ?
- How much does https://doi.org/10.1016%2Fj.arr.2015.01.002 gross monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25625901's total income per month
- What's http://scholar.google.com/scholar_lookup?&title=Resveratrol%20supplementation%3A%20where%20are%20we%20now%20and%20where%20should%20we%20go%3F&journal=Ageing%20Res%20Rev&doi=10.1016%2Fj.arr.2015.01.002&volume=21&pages=1-15&publication_year=2015&author=Novelle%2CMG&author=Wahl%2CD&author=Dieguez%2CC&author=Bernier%2CM&author=Cabo%2CR's gross income?
- How much does https://doi.org/10.1016%2Fj.jnutbio.2005.01.017 rake in every month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16043028 pull in monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Resveratrol%20as%20an%20anticancer%20nutrient%3A%20molecular%20basis%2C%20open%20questions%20and%20promises&journal=J%20Nutr%20Biochem&doi=10.1016%2Fj.jnutbio.2005.01.017&volume=16&pages=449-66&publication_year=2005&author=Signorelli%2CP&author=Ghidoni%2CR produce monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Resveratrol%20enhances%20chemosensitivity%20of%20doxorubicin%20in%20multidrug-resistant%20human%20breast%20cancer%20cells%20via%20increased%20cellular%20influx%20of%20doxorubicin&journal=Biochim%20Biophys%20Acta&volume=2014&pages=615-25&publication_year=1840&author=Kim%2CTH&author=Shin%2CYJ&author=Won%2CAJ&author=Lee%2CBM&author=Choi%2CWS&author=Jung%2CJH&author=Chung%2CHY&author=Kim%2CHS earns monthly
- How much money does https://doi.org/10.1016%2Fj.bbrc.2010.03.147 generate?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20350534?
- How much money does http://scholar.google.com/scholar_lookup?&title=Resveratrol-mediated%20reversal%20of%20doxorubicin%20resistance%20in%20acute%20myeloid%20leukemia%20cells%20via%20downregulation%20of%20MRP1%20expression&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2010.03.147&volume=395&pages=104-10&publication_year=2010&author=Kweon%2CSH&author=Song%2CJH&author=Kim%2CTS generate?
- https://doi.org/10.1097%2FPAI.0b013e3181a13bf2's revenue stream
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19407655?
- How much does http://scholar.google.com/scholar_lookup?&title=Survivin%20expression%20quantified%20by%20Image%20Pro-Plus%20compared%20with%20visual%20assessment&journal=Appl%20Immunohistochem%20Mol%20Morphol&doi=10.1097%2FPAI.0b013e3181a13bf2&volume=17&pages=530-5&publication_year=2009&author=Wang%2CCJ&author=Zhou%2CZG&author=Holmqvist%2CA&author=Zhang%2CH&author=Li%2CY&author=Adell%2CG&author=Sun%2CXF net monthly?
- How much income does https://doi.org/10.1016%2Fj.brainresprot.2005.10.002 have?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16310404 earns monthly
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=A%20simple%20and%20fast%20densitometric%20method%20for%20the%20analysis%20of%20tyrosine%20hydroxylase%20immunoreactivity%20in%20the%20substantia%20nigra%20pars%20compacta%20and%20in%20the%20ventral%20tegmental%20area&journal=Brain%20Res%20Brain%20Res%20Protoc&doi=10.1016%2Fj.brainresprot.2005.10.002&volume=16&pages=58-64&publication_year=2005&author=Xavier%2CLL&author=Viola%2CGG&author=Ferraz%2CAC&author=Cunha%2CC&author=Deonizio%2CJM&author=Netto%2CCA&author=Achaval%2CM?
- How much income does https://doi.org/10.1016%2Fj.drup.2009.07.001 have?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19648052 income
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Understanding%20the%20causes%20of%20multidrug%20resistance%20in%20cancer%3A%20a%20comparison%20of%20doxorubicin%20and%20sunitinib&journal=Drug%20Resist%20Updat&doi=10.1016%2Fj.drup.2009.07.001&volume=12&pages=114-26&publication_year=2009&author=Broxterman%2CHJ&author=Gotink%2CKJ&author=Verheul%2CHM generate?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23055201?
- How much does http://scholar.google.com/scholar_lookup?&title=Activation%20of%20beta-catenin%20signaling%20is%20critical%20for%20doxorubicin-induced%20epithelial-mesenchymal%20transition%20in%20BGC-823%20gastric%20cancer%20cell%20line&journal=Tumour%20Biol&doi=10.1007%2Fs13277-012-0548-3&volume=34&pages=277-84&publication_year=2013&author=Han%2CR&author=Xiong%2CJ&author=Xiao%2CR&author=Altaf%2CE&author=Wang%2CJ&author=Liu%2CY&author=Xu%2CH&author=Ding%2CQ&author=Zhang%2CQ bring in each month?
- How much cash flow does https://doi.org/10.1016%2Fj.cell.2009.11.007 have monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19945376 generate?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20transitions%20in%20development%20and%20disease&journal=Cell&doi=10.1016%2Fj.cell.2009.11.007&volume=139&pages=871-90&publication_year=2009&author=Thiery%2CJP&author=Acloque%2CH&author=Huang%2CRY&author=Nieto%2CMA have monthly?
- Find out how much https://doi.org/10.1016%2Fj.canlet.2016.02.048 earns monthly
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26945971?
- http://scholar.google.com/scholar_lookup?&title=Cancer%20development%2C%20chemoresistance%2C%20epithelial%20to%20mesenchymal%20transition%20and%20stem%20cells%3A%20A%20snapshot%20of%20IL-6%20mediated%20involvement&journal=Cancer%20Lett&doi=10.1016%2Fj.canlet.2016.02.048&volume=375&pages=51-61&publication_year=2016&author=Bharti%2CR&author=Dey%2CG&author=Mandal%2CM's revenue stream
- What are the total earnings of https://doi.org/10.1038%2Fcr.2009.5?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19153598?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720263?
- What's http://scholar.google.com/scholar_lookup?&title=TGF-beta-induced%20epithelial%20to%20mesenchymal%20transition&journal=Cell%20Res&doi=10.1038%2Fcr.2009.5&volume=19&pages=156-72&publication_year=2009&author=Xu%2CJ&author=Lamouille%2CS&author=Derynck%2CR's gross income?
- Get to know https://doi.org/10.1038%2Femm.2013.115's earnings
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24263233
- What's the monthly income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849569?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Phosphoproteomic%20analysis%20identifies%20activated%20MET-axis%20PI3K%2FAKT%20and%20MAPK%2FERK%20in%20lapatinib-resistant%20cancer%20cell%20line&journal=Exp%20Mol%20Med&doi=10.1038%2Femm.2013.115&volume=45&publication_year=2013&author=Lee%2CYY&author=Kim%2CHP&author=Kang%2CMJ&author=Cho%2CBK&author=Han%2CSW&author=Kim%2CTY&author=Yi%2CEC?
- Revenue of https://doi.org/10.1038%2Fnature15748
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26560033's earnings
- Get to know http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662610's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=Epithelial-to-mesenchymal%20transition%20is%20not%20required%20for%20lung%20metastasis%20but%20contributes%20to%20chemoresistance&journal=Nature&doi=10.1038%2Fnature15748&volume=527&pages=472-6&publication_year=2015&author=Fischer%2CKR&author=Durrans%2CA&author=Lee%2CS&author=Sheng%2CJ&author=Li%2CF&author=Wong%2CST&author=Choi%2CH&author=Rayes%2CT&author=Ryu%2CS&author=Troeger%2CJ make?
- How much cash flow does https://doi.org/10.1016%2Fj.critrevonc.2016.01.024 have monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26852079 generate?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Resistance%20mechanisms%20after%20tyrosine%20kinase%20inhibitors%20afatinib%20and%20crizotinib%20in%20non-small%20cell%20lung%20cancer%2C%20a%20review%20of%20the%20literature&journal=Crit%20Rev%20Oncol%20Hematol&doi=10.1016%2Fj.critrevonc.2016.01.024&volume=100&pages=107-16&publication_year=2016&author=Wekken%2CAJ&author=Saber%2CA&author=Hiltermann%2CTJ&author=Kok%2CK&author=Berg%2CA&author=Groen%2CHJ produce monthly?
- How much does https://doi.org/10.3748%2Fwjg.v21.i43.12261 generate monthly?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26604635
- Income figures for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649111
- How much does http://scholar.google.com/scholar_lookup?&title=Targeting%20the%20PI3K%2FAkt%20signaling%20pathway%20in%20gastric%20carcinoma%3A%20a%20reality%20for%20personalized%20medicine%3F&journal=World%20J%20Gastroenterol&doi=10.3748%2Fwjg.v21.i43.12261&volume=21&pages=12261-73&publication_year=2015&author=Singh%2CSS&author=Yap%2CWN&author=Arfuso%2CF&author=Kar%2CS&author=Wang%2CC&author=Cai%2CW&author=Dharmarajan%2CAM&author=Sethi%2CG&author=Kumar%2CAP net monthly?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12414639 makes per month
- How much does http://scholar.google.com/scholar_lookup?&title=Inhibitors%20of%20mTOR%20reverse%20doxorubicin%20resistance%20conferred%20by%20PTEN%20status%20in%20prostate%20cancer%20cells&journal=Cancer%20Res&volume=62&pages=6141-5&publication_year=2002&author=Grunwald%2CV&author=DeGraffenried%2CL&author=Russel%2CD&author=Friedrichs%2CWE&author=Ray%2CRB&author=Hidalgo%2CM make?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25031754 making per month?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097285 gross monthly?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Phosphorylation%20status%20of%20Akt%20and%20caspase-9%20in%20gastric%20and%20colorectal%20carcinomas&journal=Int%20J%20Clin%20Exp%20Pathol&volume=7&pages=3312-7&publication_year=2014&author=Sangawa%2CA&author=Shintani%2CM&author=Yamao%2CN&author=Kamoshida%2CS?
- What's the total monthly financial gain of https://doi.org/10.1016/j.semcancer.2015.03.001?
- How much money does https://doi.org/10.1038%2Fonc.2010.421 generate?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20856200
- How much profit does http://scholar.google.com/scholar_lookup?&title=Vimentin%20is%20a%20novel%20AKT1%20target%20mediating%20motility%20and%20invasion&journal=Oncogene&doi=10.1038%2Fonc.2010.421&volume=30&pages=457-70&publication_year=2011&author=Zhu%2CQS&author=Rosenblatt%2CK&author=Huang%2CKL&author=Lahat%2CG&author=Brobey%2CR&author=Bolshakov%2CS&author=Nguyen%2CT&author=Ding%2CZ&author=Belousov%2CR&author=Bill%2CK make?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18383865's financial summary
- How much does http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20vimentin%20contributes%20to%20prostate%20cancer%20invasion%20and%20metastasis%20via%20src%20regulation&journal=Anticancer%20Res&volume=28&pages=327-34&publication_year=2008&author=Wei%2CJ&author=Xu%2CG&author=Wu%2CM&author=Zhang%2CY&author=Li%2CQ&author=Liu%2CP&author=Zhu%2CT&author=Song%2CA&author=Zhao%2CL&author=Han%2CZ generate monthly?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25047112?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223686?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Study%20of%20beta-catenin%2C%20E-cadherin%20and%20vimentin%20in%20oral%20squamous%20cell%20carcinoma%20with%20and%20without%20lymph%20node%20metastases&journal=Diagn%20Pathol&doi=10.1186%2F1746-1596-9-145&volume=9&publication_year=2014&author=Balasundaram%2CP&author=Singh%2CMK&author=Dinda%2CAK&author=Thakar%2CA&author=Yadav%2CR?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21327330 earn?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Vimentin%20expression%20is%20associated%20with%20decreased%20survival%20in%20gastric%20cancer&journal=Oncol%20Rep&volume=25&pages=1235-42&publication_year=2011&author=Otsuki%2CS&author=Inokuchi%2CM&author=Enjoji%2CM&author=Ishikawa%2CT&author=Takagi%2CY&author=Kato%2CK&author=Yamada%2CH&author=Kojima%2CK&author=Sugihara%2CK
- How much does https://doi.org/10.7150%2Fthno.15083 net monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27279912 rake in every month?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893646 earn?
- How much does http://scholar.google.com/scholar_lookup?&title=Gas6%2FAxl%20axis%20contributes%20to%20chemoresistance%20and%20metastasis%20in%20breast%20cancer%20through%20Akt%2FGSK-3beta%2Fbeta-catenin%20signaling&journal=Theranostics&doi=10.7150%2Fthno.15083&volume=6&pages=1205-19&publication_year=2016&author=Wang%2CC&author=Jin%2CH&author=Wang%2CN&author=Fan%2CS&author=Wang%2CY&author=Zhang%2CY&author=Wei%2CL&author=Tao%2CX&author=Gu%2CD&author=Zhao%2CF bring in each month?
- How much profit does https://doi.org/10.1007/s10620-016-4116-3 generate?
- How much does https://doi.org/10.1016%2Fj.phymed.2015.12.020 bring in each month?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26969377?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Resveratrol%20improves%20the%20anticancer%20effects%20of%20doxorubicin%20in%20vitro%20and%20in%20vivo%20models%3A%20a%20mechanistic%20insight&journal=Phytomedicine&doi=10.1016%2Fj.phymed.2015.12.020&volume=23&pages=233-42&publication_year=2016&author=Rai%2CG&author=Mishra%2CS&author=Suman%2CS&author=Shukla%2CY have monthly?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26530632?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Resveratrol%20induces%20cell%20cycle%20arrest%20in%20human%20gastric%20cancer%20MGC803%20cells%20via%20the%20PTEN-regulated%20PI3K%2FAkt%20signaling%20pathway&journal=Oncol%20Rep&volume=35&pages=472-8&publication_year=2016&author=Jing%2CX&author=Cheng%2CW&author=Wang%2CS&author=Li%2CP&author=He%2CL?
- https://doi.org/10.1016%2Fj.bcp.2014.09.002 income
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25219324's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=Resveratrol%20inhibits%20epithelial-mesenchymal%20transition%20and%20renal%20fibrosis%20by%20antagonizing%20the%20hedgehog%20signaling%20pathway&journal=Biochem%20Pharmacol&doi=10.1016%2Fj.bcp.2014.09.002&volume=92&pages=484-93&publication_year=2014&author=Bai%2CY&author=Lu%2CH&author=Wu%2CC&author=Liang%2CY&author=Wang%2CS&author=Lin%2CC&author=Chen%2CB&author=Xia%2CP make?
- What is the monthly revenue of https://citation-needed.springer.com/v2/references/10.1186/s13046-016-0487-8?format=refman&flavour=references?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jiahui%20Xu bring in?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jiahui%20Xu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Deying%20Liu's gross income?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Deying%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Huilin%20Niu income
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Huilin%20Niu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Guifang%20Zhu
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Guifang%20Zhu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yangwei%20Xu
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yangwei%20Xu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Danli%20Ye?
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Danli%20Ye%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jian%20Li?
- What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jian%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Qingling%20Zhang's earnings
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Qingling%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- What's http://creativecommons.org/licenses/by/4.0/'s gross income?
- What's the income generated by http://creativecommons.org/publicdomain/zero/1.0/ each month?
- Profit of https://s100.copyright.com/AppDispatchServlet?title=Resveratrol%20reverses%20Doxorubicin%20resistance%20by%20inhibiting%20epithelial-mesenchymal%20transition%20%28EMT%29%20through%20modulating%20PTEN%2FAkt%20signaling%20pathway%20in%20gastric%20cancer&author=Jiahui%20Xu%20et%20al&contentID=10.1186%2Fs13046-016-0487-8©right=The%20Author%28s%29.&publication=1756-9966&publicationDate=2017-01-26&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0
- How much does https://crossmark.crossref.org/dialog/?doi=10.1186/s13046-016-0487-8 bring in each month?
- How much does https://citation-needed.springer.com/v2/references/10.1186/s13046-016-0487-8?format=refman&flavour=citation generate monthly?
- Discover the revenue of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- What's the income of https://www.springernature.com/gp/products?
- What's https://www.springernature.com/gp/librarians's gross income?
- How much revenue does https://www.springernature.com/gp/societies generate?
- Financial intake of https://www.springernature.com/gp/partners
- Get to know https://www.springer.com/'s earnings
- How much money does https://www.nature.com/ generate?
- How much does https://www.biomedcentral.com/ earn?
- Learn how profitable https://www.palgrave.com/ is on a monthly basis
- What is the monthly revenue of https://www.apress.com/?
- Get to know what's the income of https://www.springernature.com/gp/legal/ccpa
- Discover the revenue of https://www.springernature.com/gp/info/accessibility
- What is the monthly revenue of https://support.springernature.com/en/support/home?
- What's the income of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- What are the total earnings of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref